Evidence map›Paper›PMID 30135398›Full record

ReviewBiomedicines2018

Contributions of Thyroid Hormone to Cancer Metastasis.

Shaker A Mousa, Gennadi V Glinsky, Hung-Yun Lin, Osnat Ashur-Fabian, Aleck Hercbergs, Kelly A Keating, Paul J Davis

Open access · goldAbstract readReview
In one paragraph

Review in Biomedicines, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed
4.6field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed, 53 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. The power of heteronemin in cancers.Journal of biomedical science · 2022
    Review
  5. Article
  6. Article
  7. Review
  8. Review
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Actions of Thyroid Hormones on Thyroid Cancers.Frontiers in endocrinology · 2021
    Review
  16. Review
  17. Review
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 5 institutions in 3 countries.

Shaker A MousaPharmaceutical Research Institute, Albany College of Pharmacy and Health Sciences, Rensselaer, NY 12144, USA. shaker.mousa@acphs.edu.ORCID 0000-0002-9294-015X
Gennadi V GlinskyInstitute of Engineering in Medicine, University of California, San Diego, CA 92093, USA. gglinskii@ucsd.edu.
Hung-Yun LinPharmaceutical Research Institute, Albany College of Pharmacy and Health Sciences, Rensselaer, NY 12144, USA. linhy@tmu.edu.tw.
Osnat Ashur-FabianDepartment of Human Molecular Genetics and Biochemistry, Tel Aviv University, Tel Aviv 69978, Israel. osnataf@gmail.com.
Aleck HercbergsDepartment of Radiation Oncology, Cleveland Clinic, Cleveland, OH 44195, USA. hercbergs@gmail.com.
Kelly A KeatingPharmaceutical Research Institute, Albany College of Pharmacy and Health Sciences, Rensselaer, NY 12144, USA. kelly.keating@acphs.edu.ORCID 0000-0002-1767-6379
Paul J DavisPharmaceutical Research Institute, Albany College of Pharmacy and Health Sciences, Rensselaer, NY 12144, USA. pdavis.ordwayst@gmail.com.ORCID 0000-0002-6794-4917
Albany College of Pharmacy and Health Sciences · USCleveland Clinic · USTaipei Medical University Hospital · TWTel Aviv University · ILUniversity of California San Diego · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Acting at a cell surface receptor on the extracellular domain of integrin αvβ3, thyroid hormone analogues regulate downstream the expression of a large panel of genes relevant to cancer cell proliferation, to cancer cell survival pathways, and to tumor-linked angiogenesis. Because αvβ3 is involved in the cancer cell metastatic process, we examine here the possibility that thyroid hormone as l-thyroxine (T4) and the thyroid hormone antagonist, tetraiodothyroacetic acid (tetrac), may respectively promote and inhibit metastasis. Actions of T4 and tetrac that are relevant to cancer metastasis include the multitude of synergistic effects on molecular levels such as expression of matrix metalloproteinase genes, angiogenesis support genes, receptor tyrosine kinase (

Indexed as

angiogenesiscancercancer cell genesepithelial-to-mesenchymal transition (EMT)integrin αvβ3l-thyroxinematrix metalloproteinasesmetastasisT4tetracthyroid hormone

Identifiers

PMID30135398
PMCPMC6165185
OpenAlexW2888685985

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.